1.
Rawson NSB. Alignment of health technology assessments and price negotiations for new drugs for rare disorders in Canada: Does it lead to improved patient access?. J Popl Ther Clin Pharmacol. 2020;27(1):e48-e64. doi:10.15586/jptcp.v27i1.658